We provide you with 20 years of free, institutional-grade data for OCUL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OCUL. Explore the full financial landscape of OCUL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$367,864
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Notman Donald | Sale | -1,066 | $12.43 | $13,250 | 2025-09-04 |
| Kaiser Peter | Sale | -3,011 | $12.04 | $36,252 | 2025-08-27 |
| Dugel Pravin | Sale | -21,494 | $12.04 | $258,788 | 2025-08-27 |
| Nayak Sanjay | Sale | -1,885 | $12.04 | $22,695 | 2025-08-27 |
| Heier Jeffrey S. | Sale | -3,063 | $12.04 | $36,879 | 2025-08-27 |
| Waheed Nadia | Grant, award...etc | 40,363 | 2025-08-14 | ||
| Meyers Steve Lawrence | Initial | 2025-06-23 | |||
| Saroj Namrata | Initial | 2025-06-23 | |||
| Williams Leslie J. | Grant, award...etc | 14,000 | 2025-06-13 | ||
| Warden Charles M | Grant, award...etc | 14,000 | 2025-06-13 | ||
| Graves Adrienne L | Grant, award...etc | 14,000 | 2025-06-13 | ||
| RAINES MERILEE | Grant, award...etc | 14,000 | 2025-06-13 | ||
| LINDSTROM RICHARD L MD | Grant, award...etc | 14,000 | 2025-06-13 | ||
| Hong Seung Suh | Grant, award...etc | 14,000 | 2025-06-13 | ||
| Waheed Nadia | Sale | -13,861 | $8.05 | $111,581 | 2025-06-03 |
| Heier Jeffrey S. | Sale | -3,024 | $7.18 | $21,712 | 2025-05-27 |
| Dugel Pravin | Sale | -21,219 | $7.18 | $152,352 | 2025-05-27 |
| Nayak Sanjay | Sale | -1,862 | $7.17 | $13,351 | 2025-05-27 |
| Kaiser Peter | Sale | -2,974 | $7.17 | $21,324 | 2025-05-27 |
| LINDSTROM RICHARD L MD | Open Market Purchase | 10,000 | $6.96 | 2025-05-12 | |
| Nayak Sanjay | Sale | -1,895 | $6.84 | $12,962 | 2025-02-26 |
| Heier Jeffrey S. | Sale | -3,061 | $6.87 | $21,029 | 2025-02-26 |
| Kaiser Peter | Sale | -3,009 | $6.87 | $20,672 | 2025-02-26 |
| Dugel Pravin | Sale | -21,475 | $6.87 | $147,533 | 2025-02-26 |
| Nayak Sanjay | Grant, award...etc | 111,000 | 2025-02-13 | ||
| Notman Donald | Grant, award...etc | 115,000 | 2025-02-13 | ||
| Waheed Nadia | Grant, award...etc | 79,000 | 2025-02-13 | ||
| Dugel Pravin | Grant, award...etc | 2,750,000 | 2025-02-13 | ||
| Notman Donald | Sale | -17,420 | $7.84 | $136,573 | 2025-02-04 |
| Dugel Pravin | Sale | -20,680 | $9.01 | $186,327 | 2024-11-27 |
| Nayak Sanjay | Sale | -1,814 | $9 | $16,326 | 2024-11-27 |
| Kaiser Peter | Sale | -2,897 | $9.01 | $26,102 | 2024-11-27 |
| Heier Jeffrey S. | Sale | -2,948 | $9.01 | $26,561 | 2024-11-27 |
| Anderman Todd | Grant, award...etc | 98,700 | 2024-10-09 | ||
| Kaiser Peter | Initial | 2024-10-04 | |||
| Heier Jeffrey S. | Grant, award...etc | 100,000 | 2024-10-04 | ||
| Kaiser Peter | Grant, award...etc | 100,000 | 2024-10-04 | ||
| Heier Jeffrey S. | Initial | 2024-10-04 | |||
| Notman Donald | Grant, award...etc | 11,034 | 2024-09-03 | ||
| Nayak Sanjay | Sale | -1,832 | $9.02 | $16,525 | 2024-08-27 |
| Dugel Pravin | Sale | -20,880 | $9.02 | $188,338 | 2024-08-27 |
| Warden Charles M | Grant, award...etc | 12,000 | 2024-07-26 | ||
| Graves Adrienne L | Grant, award...etc | 12,000 | 2024-07-26 | ||
| Williams Leslie J. | Grant, award...etc | 12,000 | 2024-07-26 | ||
| LINDSTROM RICHARD L MD | Grant, award...etc | 12,000 | 2024-07-26 | ||
| LINDSTROM RICHARD L MD | Derivatives Exercise | 30,302 | 2024-07-26 | ||
| RAINES MERILEE | Grant, award...etc | 12,000 | 2024-07-26 | ||
| Hong Seung Suh | Grant, award...etc | 12,000 | 2024-07-26 | ||
| Waheed Nadia | Grant, award...etc | 141,666 | 2024-06-04 | ||
| Dugel Pravin | Sale | -21,626 | $5.79 | $125,215 | 2024-05-28 |
| Nayak Sanjay | Sale | -2,274 | $5.84 | $13,280 | 2024-05-28 |
| SUMMER ROAD LLC | Open Market Purchase | 930,851 | $7.52 | 2024-02-27 | |
| Nayak Sanjay | Initial | 2024-02-26 | |||
| Dugel Pravin | Grant, award...etc | 854,979 | 2024-02-26 | ||
| Nayak Sanjay | Grant, award...etc | 80,300 | 2024-02-26 | ||
| Mattessich Antony C. | Sale | 19,642 | $4.86 | 2024-02-06 | |
| Mattessich Antony C. | Grant, award...etc | 180,400 | 2024-02-06 | ||
| Notman Donald | Sale | 6,212 | $4.86 | 2024-02-06 | |
| Notman Donald | Grant, award...etc | 61,636 | 2024-02-06 | ||
| Ozden Rabia Gurses | Sale | 6,346 | $4.86 | 2024-02-06 | |
| Ozden Rabia Gurses | Grant, award...etc | 66,633 | 2024-02-06 | ||
| Strassburger Philip C. | Sale | 6,029 | $4.86 | 2024-02-06 | |
| Strassburger Philip C. | Grant, award...etc | 58,304 | 2024-02-06 | ||
| White Christopher G | Sale | 5,910 | $4.86 | 2024-02-06 | |
| White Christopher G | Grant, award...etc | 39,980 | 2024-02-06 | ||
| Notman Donald | Sale | -6,433 | $4.95 | $31,843 | 2024-02-02 |
| Ozden Rabia Gurses | Sale | -7,764 | $4.95 | $38,432 | 2024-02-02 |
| White Christopher G | Sale | -5,147 | $4.95 | $25,478 | 2024-02-02 |
| Strassburger Philip C. | Sale | -6,831 | $4.95 | $33,813 | 2024-02-02 |
| Mattessich Antony C. | Sale | -18,338 | $4.95 | $90,773 | 2024-02-02 |
| SUMMER ROAD LLC | Open Market Purchase | 1,538,461 | $3.25 | 2023-12-18 | |
| Mattessich Antony C. | Open Market Purchase | 6,500 | $3.81 | 2023-09-05 | |
| Graves Adrienne L | Grant, award...etc | 24,000 | 2023-07-12 | ||
| Ozden Rabia Gurses | Sale | -832 | $4.93 | $4,102 | 2023-07-11 |
| Heier Jeffrey S. | Grant, award...etc | 12,000 | 2023-06-16 | ||
| Hong Seung Suh | Grant, award...etc | 12,000 | 2023-06-16 |
The information provided in this report about OCUL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ocular Therapeutix, Inc(NASDAQ:OCUL) 
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent...
Website: http://www.ocutx.com
Founded: 2006
Full Time Employees: 161
CEO: Antony Mattessich
Sector: Healthcare
Industry: Biotechnology